Not exactly... Still lots of work to do.. they need to fix the issues with units, launch the pen and partners pens, maybe a little update on the status of medical processes like the trials or the medical device approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.